ketoconazole has been researched along with Bright Disease in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In contrast, in four patients with polycystic kidney disease, progression accelerated by 99% +/- 63%." | 2.68 | Effect of ketoconazole plus low-dose prednisone on progression of chronic renal failure. ( Hill, S; Walser, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walser, M | 1 |
| Hill, S | 1 |
1 trial available for ketoconazole and Bright Disease
| Article | Year |
|---|---|
Effect of ketoconazole plus low-dose prednisone on progression of chronic renal failure.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Diabetic Nephropath | 1997 |